Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析

◆英語タイトル:Kane Biotech Inc (KNE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH15200FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kane Biotech Inc (Kane Biotech) is a biotechnology company which focuses on research, development and commercialization of novel products that prevent and remove biofilm related infections in humans and animals. The company’s products include StrixNB and Vetradent water additive, oral spray, powder and toothpaste, designed for treating dental diseases in dogs; Alosera, an anti-biofilm and anti-microbial shampoo, being developed against atopic dermatitis in dogs, cats and horses; and DispersinB, for treatment of wounds and chronic ear infections in animals and humans. It designed Aledex, an anti-biofilm medical device coating to prevent clinical infections associated with medical devices. Kane Biotech is also developing solutions for human inflammatory skin diseases such as atopic dermatitis, seborrheic dermatitis and athlete’s foot. The company serves commercial, industrial and institutional sectors. It conducts research and development programs through its on-site CL2 biofilm research laboratory in Canada. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.

Kane Biotech Inc Key Recent Developments

Mar 25,2021: Kane Biotech Announces Fourth Quarter and Full Year 2020 Financial Results
Mar 11,2021: Kane Biotech to participate in Maxim Group inaugural emerging growth conference
Feb 24,2021: Kane Biotech announces new chairman
Nov 26,2020: Kane Biotech announces third quarter 2020 financial results
Oct 13,2020: STEM Animal Health appoints new president and CEO

This comprehensive SWOT profile of Kane Biotech Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Kane Biotech Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Kane Biotech Inc – Key Information
Kane Biotech Inc – Overview
Kane Biotech Inc – Key Employees
Kane Biotech Inc – Key Employee Biographies
Kane Biotech Inc – Key Operational Heads
Kane Biotech Inc – Major Products and Services
Kane Biotech Inc – History
Kane Biotech Inc – Company Statement
Kane Biotech Inc – Locations And Subsidiaries
Kane Biotech Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Kane Biotech Inc – Business Description
Kane Biotech Inc – Corporate Strategy
Kane Biotech Inc – SWOT Analysis
SWOT Analysis – Overview
Kane Biotech Inc – Strengths
Kane Biotech Inc – Weaknesses
Kane Biotech Inc – Opportunities
Kane Biotech Inc – Threats
Kane Biotech Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Kane Biotech Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Kane Biotech Inc, Key Information
Kane Biotech Inc, Key Ratios
Kane Biotech Inc, Share Data
Kane Biotech Inc, Major Products and Services
Kane Biotech Inc, History
Kane Biotech Inc, Key Employees
Kane Biotech Inc, Key Employee Biographies
Kane Biotech Inc, Key Operational Heads
Kane Biotech Inc, Other Locations
Kane Biotech Inc, Subsidiaries
Kane Biotech Inc, Key Competitors
Kane Biotech Inc, SWOT Analysis
Kane Biotech Inc, Ratios based on current share price
Kane Biotech Inc, Annual Ratios
Kane Biotech Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dilafor AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Dilafor AB (Dilafor) is a drug development company that develops pharmaceutical products for obstetric indications. The company offers tafoxiparin, a proprietary heparan sulfate mimetic, which is used as an adjuvant therapy to promote cervical ripening and myometrial contractility. Its tafox …
  • Luna Innovations Inc (LUNA):企業の製品パイプライン分析
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • Ampac Packaging, LLC:企業の戦略・SWOT・財務情報
    Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report Summary Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Microbiotix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Microbiotix Inc (Microbiotix) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of infectious diseases. The company provides products for hepatitis C virus and human cytomegalovirus including HCV NS5B MBX-700, MBX-701 and MBX-400. It also provi …
  • Les Laboratoires Servier:企業の戦略・SWOT・財務分析
    Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report Summary Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Siemens AG:企業のM&A・事業提携・投資動向
    Siemens AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Siemens AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Ducommun Incorporated:戦略・SWOT・企業財務分析
    Ducommun Incorporated - Strategy, SWOT and Corporate Finance Report Summary Ducommun Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Daiwa Securities Group Inc:戦略・SWOT・企業財務分析
    Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report Summary Daiwa Securities Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Dexus Property Group:企業のM&A・事業提携・投資動向
    Dexus Property Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexus Property Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Metropolitan Bank & Trust Company (MBT):企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Autolus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Autolus Ltd (Autolus) is a biopharmaceutical company that develops anticancer therapies. The company uses T-cell programming and manufacturing technology to develop and commercialize T-cell therapies for cancer treatment. It uses chimeric antigen receptors (CARs) or T-cell receptors (TCRs) t …
  • IXICO Plc (IXI):企業の財務・戦略的SWOT分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as Assessa and trial tracker. Assessa provides web-based platform to tra …
  • Kirby Corp (KEX):企業の財務・戦略的SWOT分析
    Kirby Corp (KEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Information Services International-Dentsu Ltd (4812):企業の財務・戦略的SWOT分析
    Information Services International-Dentsu Ltd (4812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • ITT Inc (ITT):企業の財務・戦略的SWOT分析
    ITT Inc (ITT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Konecranes Plc
    Konecranes Plc - Strategy, SWOT and Corporate Finance Report Summary Konecranes Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Novelion Therapeutics Inc (NVLN):企業の財務・戦略的SWOT分析
    Novelion Therapeutics Inc (NVLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hologic Inc (HOLX):企業の財務・戦略的SWOT分析
    Hologic Inc (HOLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-製薬・医療分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆